ZA849975B - Pharmaceutical preparations containing 1,2-diacylglycero-3-phosphocholines - Google Patents

Pharmaceutical preparations containing 1,2-diacylglycero-3-phosphocholines

Info

Publication number
ZA849975B
ZA849975B ZA849975A ZA849975A ZA849975B ZA 849975 B ZA849975 B ZA 849975B ZA 849975 A ZA849975 A ZA 849975A ZA 849975 A ZA849975 A ZA 849975A ZA 849975 B ZA849975 B ZA 849975B
Authority
ZA
South Africa
Prior art keywords
diacylglycero
phosphocholines
contain
fatty acid
pharmaceutical preparations
Prior art date
Application number
ZA849975A
Other languages
English (en)
Inventor
Volker Dr Schulz
Sigurd Dr Leyck
Manfred Dr Duerr
Miklos Dr Ghyczy
Armin Wendel
Joerg Hager
Original Assignee
Nattermann A & Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nattermann A & Cie filed Critical Nattermann A & Cie
Publication of ZA849975B publication Critical patent/ZA849975B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/10—Phosphatides, e.g. lecithin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA849975A 1983-12-22 1984-12-21 Pharmaceutical preparations containing 1,2-diacylglycero-3-phosphocholines ZA849975B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19833346525 DE3346525A1 (de) 1983-12-22 1983-12-22 Pharmazeutische zubereitung mit speziellen 1,2-diacyl-glycero-3-phosphocholinen zur behandlung von erkrankungen im magen-darmbereich

Publications (1)

Publication Number Publication Date
ZA849975B true ZA849975B (en) 1985-08-28

Family

ID=6217767

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA849975A ZA849975B (en) 1983-12-22 1984-12-21 Pharmaceutical preparations containing 1,2-diacylglycero-3-phosphocholines

Country Status (10)

Country Link
US (1) US4684632A (xx)
EP (1) EP0147741B1 (xx)
JP (1) JPS60169421A (xx)
AT (1) ATE45091T1 (xx)
DE (2) DE3346525A1 (xx)
DK (1) DK619884A (xx)
GR (1) GR82544B (xx)
IE (1) IE57808B1 (xx)
PT (1) PT79648B (xx)
ZA (1) ZA849975B (xx)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1260393A (en) * 1984-10-16 1989-09-26 Lajos Tarcsay Liposomes of synthetic lipids
US4626527A (en) * 1985-09-28 1986-12-02 Massachusetts Institute Of Technology Process for utilizing choline to sustain muscular performance
DK153442C (da) * 1985-10-14 1988-12-19 Poul Bachmann Middel, baseret paa pektinholdigt materiale, til behandling og forebyggelse af diarre hos mennesker og dyr
DE3613799C1 (de) * 1986-04-24 1987-09-03 Nattermann A & Cie Verwendung von Glycofurol zum Verfluessigen von Arzneimittelzubereitungen fuer das Abfuellen in Weichgelatinekapseln
GB8621816D0 (en) * 1986-09-10 1986-10-15 Efamol Ltd Therapeutic composition
US4918063A (en) * 1987-02-17 1990-04-17 Board Of Regents, The University Of Texas System Methods and compositions employing unique mixtures of polar and neutral lipids for protecting the gastrointestinal tract
US5032384A (en) * 1989-01-27 1991-07-16 Block Drug Company, Inc. Compositions and method for the treatment of disease
US5229137A (en) * 1992-05-06 1993-07-20 Brigham And Women's Hospital, Inc. Methods and pharmaceutical compositions for treating episodic heartburn
EP0582239B1 (de) * 1992-08-04 1999-08-04 Rhone-Poulenc Rorer Gmbh Pharmazeutische und/oder kosmetische Zubereitung
GB9301629D0 (en) * 1993-01-27 1993-03-17 Scotia Holdings Plc Formulations containing unsaturated fatty acids
FR2714382B1 (fr) * 1993-12-27 1996-02-02 Roussel Uclaf Phospholipides vecteur de molécule active, leur préparation et leur utilisation dans des compositions cosmétiques ou dermatologiques.
US5763422A (en) * 1995-01-27 1998-06-09 Board Of Regents, The University Of Texas System Methods of enhancing the therapeutic activity of NSAIDS and compositions of zwitterionic phospholipids useful therein
US5955451A (en) * 1995-05-12 1999-09-21 The University Of Texas System Board Of Regents Methods of enhancing the therapeutic activity of NSAIDS and compositions of zwitterionic phospholipids useful therein
DK0828495T3 (da) * 1995-06-01 2003-02-24 Searle & Co Misoprostolholdige faste stabiliserede dispersioner
FR2779651B1 (fr) * 1998-06-16 2001-04-20 Gattefosse Ets Sa Procede pour la fabrication de comprimes a liberation prolongee de principe(s) actif(s) presentant une cinetique de dissolution d'ordre zero
PL370907A1 (en) * 2002-03-07 2005-05-30 Novartis Ag Pharmaceutical compositions
AU2002346284A1 (en) * 2002-04-26 2003-11-10 Rudolf Perl Pharmaceutical compositions of phospholipid derivatives
US9006280B2 (en) * 2008-11-20 2015-04-14 Teikoku Pharma Usa, Inc. Pyrazolone derivative formulations
JP6368645B2 (ja) 2011-09-29 2018-08-01 ピーエルエックス オプコ インコーポレーテッド 胃腸管に沿った医薬の標的化放出のためのｐＨ依存性担体、それによる組成物、ならびにこれらの製造および使用
JP2023518822A (ja) 2020-03-26 2023-05-08 ピーエルエックス オプコ インコーポレイテッド ｐＨ依存的再構築が可能な医薬キャリア、その製造方法及び使用方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA725596A (en) * 1960-08-26 1966-01-11 J. Wretlind Arvid Method of preparing intravenously injectable fat emulsions free from side reactions or complications
FR2343481A1 (fr) * 1976-03-11 1977-10-07 Gerlich Norbert Composition destinee a empecher les lesions des membranes biologiques et a regenerer ces membranes une fois qu'elles ont ete endommagees
JPS54117034A (en) * 1978-02-28 1979-09-11 Nippon Shoji Kk Treating agent for consciousness and perception motion disorder
DE2856333C2 (de) * 1978-12-27 1983-09-22 A. Nattermann & Cie GmbH, 5000 Köln Oral einnehmbare Arzneimittel mit entzündungshemmender Wirkung
JPS5562010A (en) * 1978-10-31 1980-05-10 Ajinomoto Co Inc Fat emulsion for intravenous injection
US4378354A (en) * 1978-12-27 1983-03-29 A. Nattermann & Cie. Gmbh Inflammation-preventing pharmaceutical composition of oral administration
US4421747A (en) * 1978-12-27 1983-12-20 A. Nattermann & Cie. Gmbh Inflammation-preventing pharmaceutical composition of oral administration
US4528193A (en) * 1978-12-27 1985-07-09 A. Natterman & Cie. Gmbh Inflammation-preventing pharmaceutical composition of oral administration
DE2914788A1 (de) * 1979-04-11 1980-10-16 Nattermann A & Cie Parenteral applizierbare, stabile arzneimittelloesungen mit entzuendungshemmender wirkung
DE3047012A1 (de) * 1980-12-13 1982-07-22 A. Nattermann & Cie GmbH, 5000 Köln Verfahren zur abtrennung von acylierten phospholipiden aus diese enthaltenden phosphatidylcholin-produkten
DE3047011A1 (de) * 1980-12-13 1982-07-22 A. Nattermann & Cie GmbH, 5000 Köln Verfahren zur abtrennung von oel und/oder phosphatidylethanolamin aus diese enthaltenden alkoholloeslichen phosphatidylcholin-produkten
DE3047048A1 (de) * 1980-12-13 1982-07-29 A. Nattermann & Cie GmbH, 5000 Köln Verfahren zur abtrennung von oel und/oder phosphatidylethanolamin aus diese enthaltenden alkoholloeslichen phosphatidylcholin-produkten
DE3374914D1 (en) * 1982-04-12 1988-01-28 Univ Texas Methods and compositions for treating gastro-intestinal ulcer diesease

Also Published As

Publication number Publication date
PT79648B (de) 1986-10-21
JPH0577653B2 (xx) 1993-10-27
GR82544B (en) 1985-04-24
US4684632A (en) 1987-08-04
PT79648A (de) 1985-01-01
DE3346525C2 (xx) 1987-03-19
DE3346525A1 (de) 1985-07-04
IE57808B1 (en) 1993-04-21
ATE45091T1 (de) 1989-08-15
EP0147741B1 (de) 1989-08-02
JPS60169421A (ja) 1985-09-02
DK619884D0 (da) 1984-12-21
EP0147741A3 (en) 1985-12-04
IE843263L (en) 1985-06-22
DK619884A (da) 1985-06-23
EP0147741A2 (de) 1985-07-10
DE3479189D1 (en) 1989-09-07

Similar Documents

Publication Publication Date Title
ZA849975B (en) Pharmaceutical preparations containing 1,2-diacylglycero-3-phosphocholines
DE3172223D1 (en) Edible, pharmaceutical compositions and processes for making thereof
HUT40674A (en) Process for preparing inositol triphosphates and pharmaceutical compositions containing such compounds
IL105727A (en) 7-(2-mercapto-acetamido)-octahydro-6-oxopyrido[2,1-a][2]-benzazepine derivatives analogs thereof their preparation and pharmaceutical enkephalinase-inhibiting compositions containing them
PT77016B (en) Process for the preparation of topical anti-inflammatory compositions containing pyroxycame as active ingredient
HU913010D0 (en) Method for producing inhibitors of calcium ingestion
HUT65375A (en) Process for preparing n-alkyl-3-phenyl-3-(2-alkylthio-phenoxi)-propylamines and pharmaceutical compositions containing them
PT72507A (en) Process for the preparation of 3,4,5-trihydroxypiperidine derivatives having effect upon the carbohydrates and lipids metabolism and application thereof for the preparation of pharmaceutical and/or veterinary compositions having effect upon the carbohydrates and lipids metabolism
ZA886097B (en) Pharmaceutical composition for the treatment of psoriasis
IL88207A (en) Pharmaceutical compositions for the treatment of osteoporosis containing imidazole compounds
PT85515A (en) Process for the preparation of novel lecithin containing fluid compositions which act as body lubricants orcleansers
EG17137A (en) Pharmaceutical preparation for the therapeutic treatment of rheumatic diseases
GB2024010B (en) Compositions for containing fatty acids for the treatment of seborrhoeic conditions
GB2023145A (en) Hydrocortisone derivatives, their preparation and pharmaceutical compositions containing them
HUT37942A (en) Process for preparing 7-oxo-4-thia-1-azabicyclo /3.20/-hept-2-ene-derivatives of bactericidal effect and for preparing pharmaceutical compositions containing such compounds
DE3162277D1 (en) N-(4-phenyl-2-thiazolyl)-oxamidic-acid-2-ethoxyethylester, process for its preparation and pharmaceutical compositions containing this compound
AU8452791A (en) 1-phenyl-3-aryl-2-propyne-1-ones
IL94402A0 (en) Pharmaceutical compositions containing imidazodiazepines for the treatment of neurological symptoms
GR3024253T3 (en) High dose vitamin a compositions.
IL82293A0 (en) Pharmaceutical compositions for the treatment of malaria